References in Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines - Multiple Sclerosis and Related Disorders
Multiple sclerosis: The evolving diagnostic criteria for multiple sclerosis | Semantic Scholar
PLOS ONE: Volumetric MRI Markers and Predictors of Disease Activity in Early Multiple Sclerosis: A Longitudinal Cohort Study
Multiple Sclerosis Misdiagnosis - Practical Neurology
Should the symptomatic region be included in dissemination in space in MRI criteria for MS? - Abstract - Europe PMC
Multiple Sclerosis: A Primary Care Perspective - American Family Physician
A Longitudinal MR Study of the Presymptomatic Phase in a Patient with Clinically Definite Multiple Sclerosis | American Journal of Neuroradiology
Multiple sclerosis - National Blood Authority
PLOS ONE: Serum Biomarker gMS-Classifier2: Predicting Conversion to Clinically Definite Multiple Sclerosis
Earlier and more frequent diagnosis of multiple sclerosis using the McDonald criteria | Journal of Neurology, Neurosurgery & Psychiatry
New and Evolving Treatment Goals in Multiple Sclerosis – the Role of Teriflunomide - touchNEUROLOGY
MAKING THE DIAGNOSIS OF MULTIPLE SCLEROSIS | Journal of Neurology, Neurosurgery & Psychiatry
Multiple sclerosis - The Lancet
Hazard Ratios for the Development of Clinically Definite Multiple... | Download Table
Multiple Sclerosis | Basicmedical Key
Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event | NEJM
Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study - The Lancet Neurology
Multiple Sclerosis: When to Suspect—Keys to Diagnosis | Consultant360
Overview and Diagnosis of Multiple Sclerosis
IM interferon β-1a delays definite multiple sclerosis 5 years after a first demyelinating event | Neurology
Multiple Sclerosis - Summary Multiple sclerosis (MS) ... | GrepMed
Clinically Isolated Syndrome & Clinically Definite Multiple Sclerosis
Natural Course of Clinically Isolated Syndrome: A Longitudinal Analysis Using a Markov Model | Scientific Reports
Disposition of the study population. CDMS, clinically definite multiple... | Download Scientific Diagram
Kaplan-Meier Curves for the Time to Conversion to Clinically Definite... | Download Scientific Diagram
Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial - The Lancet Neurology
Long-term outcomes with teriflunomide in patients with clinically isolated syndrome: Results of the TOPIC extension study - Multiple Sclerosis and Related Disorders
